Cardiometabolic Risk and Smoking Cessation

Saturday, September 26 at 3:55pm

LAS VEGAS—Later this afternoon, Adam O. Goldstein, MD, MPH will review the best evidence on effective behavioral and pharmacotherapeutic approaches to tobacco cessation.

In “Cardiometabolic Risk and Smoking Cessation,” Goldstein will also review optimal ways to enhance office systems—including coding, billing, and patient-centered medical homes—to support tobacco cessation, as well as emerging electronic nicotine delivery systems.
____________________________________________________________________________________________________________________________________________________________________

RELATED CONTENT
Are You Equipped to Treat Tobacco Dependence?
Smokeless Tobacco Kills More Than a Quarter Million Annually
____________________________________________________________________________________________________________________________________________________________________

Goldstein will begin his presentation by discussing the toll cigarette smoking takes on rates of US deaths each year, and the significant effect that smoking cessation has on the risk of all-cause mortality and future cardiac events.

Next, he will review strategies to reduced resistance to smoking cessation treatment efforts and the power of combining cessation counseling with medication, as well as the use of tobacco registries through patient-centered medical homes.

Lastly, Goldstein will discuss medical coding and reimbursement associated with cessation efforts, the effects of electronic cigarettes, and how to best treat tobacco dependence in individuals with co-occurring substance abuse. 

"Getting people to quit smoking is both art and science—and we can do better in both!" Goldstein said.

"A difference exists between being good and achieving excellence in helping patients quit smoking—as clinicians, we can and must seek excellence. Quitting smoking reduces the risk of death by 36%, more than aspirin, beta blockers, ACE inhibitors and statins. Smoking and exposure to secondhand smoke are major factors contributing to adverse metabolic profiles, including those with diabetes and elevated cholesterol levels. Today, there are more and better treatments than ever to help patients quit smoking."

—Michael Potts